Literature DB >> 2620675

Increasing incidence of Corynebacterium group D2 strains resistant to norfloxacin and ciprofloxacin.

F Soriano, R Fernández-Roblas, J Zapardiel, J L Rodríguez-Tudela, P Avilés, M Romero.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2620675     DOI： 10.1007/bf01975179

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  8 in total

1.  [Urinary Corynebacterium group D2 infections. A hospital epidemic and antibiotic sensitivity].

Authors:  T Fosse; D Carles; C Laffont; J C Lefebvre; J P Bocquet
Journal:  Pathol Biol (Paris)       Date:  1988-06

2.  Increasing rates of in vitro resistance to ciprofloxacin and norfloxacin in isolates from urine specimens.

Authors:  D Desgrandchamps; J Munzinger
Journal:  Antimicrob Agents Chemother       Date:  1989-04       Impact factor: 5.191

3.  Activity of nine antimicrobial agents against Corynebacterium group D2 strains isolated from clinical specimens and skin.

Authors:  R Fernández-Roblas; S Prieto; M Santamaría; C Ponte; F Soriano
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

4.  "Diphtheroid" pneumonia.

Authors:  N F Jacobs; C A Perlino
Journal:  South Med J       Date:  1979-04       Impact factor: 0.954

5.  Antimicrobial susceptibility of Corynebacterium group D2.

Authors:  M Santamaría; C Ponte; I Wilhelmi; F Soriano
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

6.  [Corynebacterium group D2. Clinical study, biochemical identification and antibiotic sensitivity].

Authors:  N Marty; D Clave; B Cancet; S Henry-Ferry; J Didier
Journal:  Pathol Biol (Paris)       Date:  1988-05

Review 7.  Infections caused by antibiotic-resistant Corynebacterium group D2.

Authors:  F Soriano; R Fernández-Roblas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-06       Impact factor: 3.267

8.  Development of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacin.

Authors:  M Kresken; B Wiedemann
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191
  8 in total
  5 in total

1.  In vitro activity of 79 antimicrobial agents against Corynebacterium group D2.

Authors:  J A García-Rodriguez; J E García Sánchez; J L Muñoz Bellido; T Nebreda Mayoral; E García Sánchez; I García García
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

2.  Activities of gemifloxacin and five other antimicrobial agents against Listeria monocytogenes and coryneform bacteria isolated from clinical samples.

Authors:  L Martínez-Martínez; P Joyanes; A I Suárez; E J Perea
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

Review 3.  Clinical microbiology of coryneform bacteria.

Authors:  G Funke; A von Graevenitz; J E Clarridge; K A Bernard
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

4.  Activities of ABT-773 against Listeria monocytogenes and coryneform bacteria of clinical interest.

Authors:  María del Carmen Conejo; Luis Martínez-Martínez; Alvaro Pascual; Ana Isabel Suárez; Evelio J Perea
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

5.  Treatment of encrusted cystitis caused by Corynebacterium group D2 with norfloxacin, ciprofloxacin, and teicoplanin in an experimental model in rats.

Authors:  F Soriano; J L Rodriguez-Tudela; C Castilla; P Avilés
Journal:  Antimicrob Agents Chemother       Date:  1991-12       Impact factor: 5.191
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.